Authors' credentials and e-mail addresses are not used for other purposes.
The submitted articles should be previously unpublished and should not be under consideration by any other journal.
If the whole or a part of the submitted articles are presented in any congress, this should be noted in the submitted article.
The journal's Editorial Board handles all appeal and complaint cases within the scope of Committee on Publication Ethics (COPE) guidelines. In such cases, authors should contact the editorial office directly regarding their appeals and complaints. When needed, an ombudsperson may be assigned to resolve cases that cannot be resolved internally. The Editor in Chief is the final authority in the decision-making process for all appeals and complaints.
The editorial and publication processes of the journal are shaped following the guidelines of the International Council of Medical Journal Editors (ICMJE).
The journal conforms to the Principles of Transparency and Best Practice in Scholarly Publishing (DOAJ).
Originality, high scientific quality, and citation potential are the most important criteria for a manuscript to be accepted for publication. Manuscripts submitted for evaluation should not have been previously presented or already published in an electronic or printed medium. Manuscripts presented in a meeting should be submitted with detailed information on the organization, including the name, date, and location of the organization.
An approval of research protocols by the Ethics Committee following international agreements (World Medical Association Declaration of Helsinki "Ethical Principles for Medical Research Involving Human Subjects" ) is required for experimental, clinical, and drug studies and some case reports.
For all research that requires ethics committee permission ethics committee approval should be obtained, this approval should be stated and documented in the article.
In studies that require ethics committee permission, information about the permission (name of the committee, date, and number) can be found in the method section, as well as on one of the first/last pages of the article; In case reports, information about signing the informed consent/consent form should be included in the article.
• For manuscripts concerning experimental research on humans, a statement should be included that shows that written informed consent of patients and volunteers was obtained following a detailed explanation of the procedures they may undergo.
• For studies carried out on animals, the measures taken to prevent pain and suffering of the animals should be stated clearly.
• Information on patient consent, the name of the ethics committee, and the ethics committee approval number should also be stated in the Materials and Methods section of the manuscript.
• It is the authors' responsibility to protect the patients' anonymity carefully. For photographs that may reveal the identity of the patients, releases signed by the patient or their legal representative should be enclosed.
All submissions are screened by a similarity detection software (iThenticate), and the limitation without similarity is 20%.

The Endourology Bulletin holds national and international copyright for all published content. If a submission is rejected for publication, the copyright is automatically returned to the authors.

Authors do not receive any royalties or financial compensation for articles published in the journal. Additionally, no fees are charged for manuscript submission, peer review, or publication.

The copyright terms for each published article are explicitly stated in the publication files and on the journal’s website. Manuscripts submitted to the Endourology Bulletin must be accompanied by the "Copyright Agreement&Acknowledgment of Authorship Form".

Authors are responsible for ensuring that their work does not infringe upon any existing copyrights. If content such as figures, tables, or other materials—whether in print or electronic format—is borrowed from other sources, authors must obtain appropriate permissions from the copyright holders. Legal, financial, and criminal liabilities arising from copyright violations rest solely with the authors.

All content published in the Endourology Bulletin is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license. This license grants the right to share, copy, redistribute, remix, adapt, and build upon the material for any purpose except commercial use, provided that proper attribution is given and the derivative work is distributed under the same license.

Scope of License:
The CC BY-NC-SA 4.0 license grants users the freedom to:
Share – Copy and redistribute the material in any medium or format.
Adapt – Remix, transform, and build upon the material.

Conditions:
Attribution must be provided to the original authors.
Adaptations must be licensed under the same terms.
The work cannot be used for commercial purposes.

Author Responsibilities
Copyright Agreement: Authors must review and accept the terms outlined in the "Copyright Agreement&Acknowledgment of Authorship Form" before submitting their manuscript. A signed copy of this agreement must be uploaded along with the submission.

Originality of Work: Authors confirm that the submitted manuscript is their original creation and does not involve plagiarism. Any third-party materials used must be properly cited in accordance with the CC BY-NC-SA 4.0 license.

Author Accountability: Each author has individually contributed to the work and is fully responsible for its content. Authors also confirm compliance with citation standards and licensing terms.

Approval of Submission: All authors must review and approve the final version of the manuscript before submission.

Prior Publication: Authors affirm that the manuscript has not been published elsewhere and is not under consideration for publication in another journal simultaneously.

Intellectual Property Compliance: Authors are responsible for ensuring that any texts, figures, or documents included in their work do not violate third-party copyrights.

Publication Authorization: Authors grant the Endourology Bulletin permission to publish the manuscript under the CC BY-NC-SA 4.0 license, recognizing the journal as the original publisher. To maintain academic integrity, proper citation must be given, including a DOI link to the publisher’s version of the article.

Third-Party Use: Authors allow third parties to freely use the published article as long as proper attribution is given and the appropriate citation details are included. The license does not restrict the integrity or ownership of the work.

MANUSCRIPT PREPARATION

Manuscripts can only be submitted through the journal's online manuscript submission and evaluation system, available at https://dergipark.org.tr/en/pub/endouroloji. Manuscripts submitted via any other medium will not be evaluated.

Manuscripts submitted to the journal will first go through a technical evaluation process where the editorial office staff will ensure that the manuscript has been prepared and submitted following the journal's guidelines.

Submissions that do not conform to the journal's guidelines will be returned to the submitting author with technical correction requests.

Corrections may be done without changing the main text.

The editor reserves the right to reject manuscripts that do not comply with the aforementioned requirements.

Authors are required to submit the following:

• Copyright Agreement&Acknowledgement of Authorship Form,
• Informed Consent Form
• ICMJE Disclosure of Interest Form
• Title Page (including Title of Manuscript, Running title, author (s) 's name, title, and institution, corresponding author's contact information, Name of the organization supporting the research)
• Main document (All articles should have an abstract before the main text).
• Figures (Jpeg format)
• Tables (max 6 tables)

Preparation of the Main Document

The articles should be written double-spaced in 12 pt, Times New Roman character and at least 2.5 cm from all edges of each page. The main text should not contain any information about the authors' names and affiliations.
Publication Types;

Type of Article	Abstract	Text (Word)	References	Table&Figures
Original Article	250	4000	30	10
Review Article	250	5000	100	10
Case Reports	300	2000	20	10

Original articles should have a structured abstract. (Objective, Material and Methods, Results, Conclusion).
For case reports, the structured abstract is not used. Limit the abstract to 300 words.
References, tables, and citations should not be used in an abstract.
Authors must include relevant keywords (3-5) on the line following the end of the abstract.
The Turkish title, abstracts, and Turkish keywords are not required for the international authors. The editorial office will provide these.

All acronyms and abbreviations used in the manuscript should be defined first, both in the abstract and in the main text. The abbreviation should be provided in parentheses following the definition.
When a drug, product, hardware, or software program is mentioned within the main text, product information, including the name of the product, the producer of the product, and city and the country of the company (including the state if in the USA), should be provided in parentheses.
For keywords, please see Medical Subject Headings (MeSH): https://meshb.nlm.nih.gov/MeSHonDemand.
All references, tables, and figures should be referred to within the main text, and they should be numbered consecutively in the order they are referred to within the main text. The symbols used must be nomenclature used standards.

1. Original Research Articles

Purpose
Original Research Articles should present the results of clinical or basic research with sufficient documentation to ensure credibility for critical readers. These articles must contribute novel insights to the field and be supported by robust data and sound methodology.

Submission Guidelines
Word Limit: Maximum 4,000 words (excluding references, tables, and figure captions).
Structure: Manuscripts must be structured as follows:
Title (in both Turkish and English)
Abstract (in both Turkish and English)
Keywords (in both Turkish and English)
Introduction
Materials and Methods
Results
Discussion
Conclusions
Figure and Table Captions (if applicable)
References
Review Process

All submitted research articles will undergo double-blind peer review to assess their scientific merit, originality, and relevance to the journal’s scope. Statistical analyses and methodology must be clearly presented and reproducible.

2. Case Reports

Purpose
Case Reports should describe unique or rare clinical cases that provide valuable insights into diagnostic challenges, treatment approaches, or novel observations. These reports should be well-documented and contribute to the advancement of medical knowledge.

Submission Guidelines
Word Limit: Maximum 2,000 words (excluding references, tables, and figure captions).
Structure: Manuscripts must be structured as follows:
Title (in both Turkish and English)
Abstract (in both Turkish and English)
Keywords (in both Turkish and English)
Introduction
Case Presentation
Discussion and Conclusion
Figure and Table Captions (if applicable)
References

Review Process
Case Reports are subject to editorial and double-blind peer review to ensure they present a significant learning opportunity, are properly referenced, and contribute to clinical practice or medical research.

3. Review Articles

Purpose
Review Articles provide a comprehensive and structured analysis of a specific topic, summarizing and critically evaluating existing literature. These articles should be well-organized and include an up-to-date synthesis of research findings.

Submission Guidelines
Word Limit: Maximum 5,000 words (excluding references, tables, and figure captions).
Structure: Manuscripts must be structured as follows:
Title (in both Turkish and English)
Abstract (in both Turkish and English)
Keywords (in both Turkish and English)
Main Text
Conclusion
Figure and Table Captions (if applicable)
References

Systematic Reviews
Authors submitting systematic reviews must adhere to PRISMA guidelines to ensure transparency and methodological rigor. The PRISMA checklist can be accessed at: PRISMA Checklist

Review Process
Review Articles will be evaluated by the editorial board and editorial and double-blind peer review for their depth of analysis, relevance, and contribution to the scientific community.

4. Letters to the Editor

Purpose
Letters to the Editor allow readers to engage in academic discussions by responding to previously published articles, presenting brief scientific observations, or addressing issues of interest to the journal’s readership.

Submission Guidelines
Structure: Manuscripts must be structured as follows:
Title (in both Turkish and English)
Keywords (in both Turkish and English)
Main Text
Figure and Table Captions (if applicable)
References

Content: Letters should be concise, focused on specific aspects of the article in question, and contribute meaningfully to the academic discourse. They may include:
Critical analysis or commentary on the methodologies, interpretations, or conclusions of a published article.
Presentation of corroborative or contradictory data that enhances the understanding of the topic.
Discussions that contextualize the article's findings within the broader field of study.

Length: Typically, letters should not exceed 1,000 words, including references.
Title: Begin with a title that references the original article, e.g., "Comment on [Article Title] by [Author Name(s)]."
Author Information: Include full names, academic affiliations, and contact details of all contributing authors.
References: Cite the original article and any other relevant literature appropriately.
Tone: Maintain a respectful and professional tone, focusing on academic critique rather than personal remarks.

Review Process:
All submitted letters will be reviewed by the editorial team to ensure clarity, academic merit, and adherence to ethical standards. Letters must be professional in tone and contribute to meaningful scholarly discourse.

5. Research Note

Purpose: A Research Note serves to disseminate brief reports of preliminary findings, novel methodologies, or significant observations that may not warrant a full-length article but are nonetheless valuable to the scientific community.
Submission Guidelines
Length: The main text should not exceed 2,000 words, excluding references, figures, and tables.
Content: Research Notes may include:
Preliminary data that suggest a potential breakthrough or novel insight.
Descriptions of innovative techniques or methodologies.
Observations that prompt further investigation or highlight emerging trends.

Structure
Organize the note with clear headings, such as:
Title (in both Turkish and English)
Abstract (in both Turkish and English)
Keywords (in both Turkish and English)
Introduction: Briefly outline the context and significance of the work.
Methods: Summarize the approach and techniques employed.
Results: Present key findings succinctly.
Discussion: Discuss the implications and potential future directions.
References: Limit to essential citations that support the work.
Figures and Tables: Include only if they enhance the clarity and impact of the note.

Review Process
Research Notes will undergo double-blind peer review to ensure scientific validity, originality, and relevance to the journal's scope.

6. Book Review

Purpose: A Book Review offers a critical evaluation of recent publications in the field, providing readers with insights into the book's content, significance, and relevance to ongoing scholarly discussions.

Submission Guidelines
Content: Reviews should:
Length: Typically between 1,500 to 2,500 words.
Summarize the book's main themes and arguments.
Assess the strengths and weaknesses of the work.
Discuss the book's contribution to the field and its relevance to current research or practice.
Situate the book within the existing literature, noting any unique perspectives or approaches.
Title: Include the book's full title, author(s), publisher, publication year, page count, and ISBN at the beginning of the review.
Tone: Maintain an objective and scholarly tone, offering balanced critiques supported by evidence.

Review Process
Book Reviews will be evaluated by the editorial team for clarity, depth of analysis, and relevance to the journal's readership

Preparation of the Figures and Tables

• The submission system should submit figures, graphics, and photographs as separate files (in JPEG/PNG format).
• The files should not be embedded in a Word document or the main document.
• When there are figure subunits, the subunits should not be merged to form a single image. Each subunit should be submitted separately through the submission system.
• Arabic numbers should number images to indicate figure subunits.
• The minimum resolution of each submitted figure should be 300 DPI.
• Figure legends should be listed at the end of the main document.
• Information or illustrations must not permit the identification of patients, and written informed consent for publication must be sought for any photograph.
• Tables should be embedded in the main document or submitted as separate files, but if tables are submitted separately, please note where it is suitable in the main text.
• Tables are limited to six tables. All tables should be numbered consecutively in the order they are used to within the main text.
• Tables legends should be listed at the end of the main document.

References

The references used in the article must be written in parenthesis at the end of the sentences.
References should be numbered in the order they appear in the text and placed at the end of the article.
References must contain surnames and initials of all authors, article title, name of the journal, the year, and the fırst and last page numbers.
Articles with 5 or more authors 'et al.' are mixed with the first three authors.
Abbreviations should be according to Index Medicus.
Authors must add the DOI (Digital object identifier) at the end of each reference.

For Examples;

Article in journal: 1. Tasci A, Tugcu V, Ozbay B, Mutlu B, Cicekler O. Stone formation in prostatic urethra after potassium-titanyl-phosphate laser ablation of the prostate for benign prostatic hyperplasia. J Endourol 2009;23:1879-81. https://doi.org/10.1089/end.2008.0596
For Books: 1.Günalp İ: Modern Üroloji. Ankara: Yargıçoğlu matbaası, 1975. Chapters in books: Anderson JL, Muhlestein JB. Extra corporeal ureteric stenting during laparoscopic pyeloplasty. Philadelphia: W.B. Saunders; 2003. p. 288-307
For website; Gaudin S. How moon landing changed technology history [Internet]. Computerworld UK. 2009 [cited 15 June 2014]. Available from: http://www.computerworlduk.com/in-depth/it-business/2387/how-moon-landing-changed-technology-history/
For conference proceeding; Proceedings of the Symposium on Robotics, Mechatronics and Animatronics in the Creative and Entertainment Industries and Arts. SSAISB 2005 Convention. University of Hertfordshire, Hatfield, UK; 2005.
For Thesis; Ercan S. Venöz yetmezlikli hastalarda kalf kası egzersizlerinin venöz fonksiyona ve kas gücüne etkisi. Suleyman Demirel University Faculty of Medicine Sports Medicine Department Thesis. Isparta: Suleyman Demirel University. 2016.

Manuscript Withdrawal & Reject
Withdrawal of the Article: Authors are required to submit a written application addressed to the Editor who has declared their withdrawal request and justification. They must wait for the Editor's response before submitting the manuscript to another journal.

Rejection: The manuscripts which are not accepted to be published are rejected with explanations.

AFTER ACCEPTANCE

If the manuscript is accepted, the acceptance letter is sent within two weeks, the last version of the manuscript is sent to the author for the last correspondence. The journal owner and the editorial board are authorized to decide which volume of the accepted article will be printed.
Authors may publish their articles on their personal or corporate websites by linking them to the appropriate cite and library rules.

Should you wish to request a change of author (name, author addition), we kindly ask that you submit this to the Editorial Board (publisher/journal address) with a letter signed by all authors before the evaluation process is completed.

For more information about withdrawals and corrections, please see the Retraction and Correction Policy page.

Publication Ethics and Publication Malpractice Statement

Instructions for authors are shaped on the recommendations of the International Committee of Medical Journal Editors ( http://www.icmje.org/recommendations/ )
The Editorial Board Members of the Journal accept to follow 'Editorial Policy' of the 'Council of Science Editors' and the guidelines provided by the Committee on Publication Ethics (COPE) the International Committee of Medical Journal Editors (ICMJE) for dealing with scientific misconduct, such as falsification of data, plagiarism, improprieties of authorship, violation of generally accepted research practices and redundant publication and duplicate publication.
Originality, high scientific quality, and citation potential are the most important criteria for a manuscript to be accepted for publication. Manuscripts submitted for evaluation should not have been previously presented or already published in an electronic or printed medium. Manuscripts presented in a meeting should be submitted with detailed information on the organization, including the name, date, and location of the organization.
An approval of research protocols by the Ethics Committee following international agreements World Medical Association Declaration of Helsinki is required for experimental, clinical, and drug studies and some case reports. If required, an equivalent official document will be requested from the authors.
In studies requiring ethics committee approval, information about permission (name, date, and number of the board) should be included in the method section and on the article's first/last page.
If there is any concern or dispute over the stıdies, we will follow the Committee on Publication Ethics (COPE) flowcharts to solve them.

Every paper published in Endourology Bulletin is licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).

Endourology Bulletin does not charge any fees for the submission, evaluation, and publication of the articles. Authors do not pay article processing fees for the studies they submit to the journal. All published articles can be accessed free of charge at “ https://endourolojibulteni.com/en/category/archive/ “. All expenses of the journal are covered by the Endourology Society.